Dataset Information

Classification of the glioma grading using radiomics analysis.

ABSTRACT: Background:Grading of gliomas is critical information related to prognosis and survival. We aimed to apply a radiomics approach using various machine learning classifiers to determine the glioma grading. Methods:We considered 285 (high grade n = 210, low grade n = 75) cases obtained from the Brain Tumor Segmentation 2017 Challenge. Manual annotations of enhancing tumors, non-enhancing tumors, necrosis, and edema were provided by the database. Each case was multi-modal with T1-weighted, T1-contrast enhanced, T2-weighted, and FLAIR images. A five-fold cross validation was adopted to separate the training and test data. A total of 468 radiomics features were calculated for three types of regions of interest. The minimum redundancy maximum relevance algorithm was used to select features useful for classifying glioma grades in the training cohort. The selected features were used to build three classifier models of logistics, support vector machines, and random forest classifiers. The classification performance of the models was measured in the training cohort using accuracy, sensitivity, specificity, and area under the curve (AUC) of the receiver operating characteristic curve. The trained classifier models were applied to the test cohort. Results:Five significant features were selected for the machine learning classifiers and the three classifiers showed an average AUC of 0.9400 for training cohorts and 0.9030 (logistic regression 0.9010, support vector machine 0.8866, and random forest 0.9213) for test cohorts. Discussion:Glioma grading could be accurately determined using machine learning and feature selection techniques in conjunction with a radiomics approach. The results of our study might contribute to high-throughput computer aided diagnosis system for gliomas.

SUBMITTER: Cho HH

PROVIDER: S-EPMC6252243 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Classification of the glioma grading using radiomics analysis.

Cho Hwan-Ho HH Lee Seung-Hak SH Kim Jonghoon J Park Hyunjin H

PeerJ 20181122

<h4>Background</h4>Grading of gliomas is critical information related to prognosis and survival. We aimed to apply a radiomics approach using various machine learning classifiers to determine the glioma grading.<h4>Methods</h4>We considered 285 (high grade <i>n</i> = 210, low grade <i>n</i> = 75) cases obtained from the Brain Tumor Segmentation 2017 Challenge. Manual annotations of enhancing tumors, non-enhancing tumors, necrosis, and edema were provided by the database. Each case was multi-moda ...[more]

PMID: 30498643

Similar Datasets

Project description:Cancer pathology reflects disease progression (or regression) and associated molecular characteristics, and provides rich phenotypic information that is predictive of cancer grade and has potential implications in treatment planning and prognosis. According to the remarkable performance of computational approaches in the digital pathology domain, we hypothesized that machine learning can help to distinguish low-grade gliomas (LGG) from high-grade gliomas (HGG) by exploiting the rich phenotypic information that reflects the microvascular proliferation level, mitotic activity, presence of necrosis, and nuclear atypia present in digital pathology images. A set of 735 whole-slide digital pathology images of glioma patients (median age: 49.65 years, male: 427, female: 308, median survival: 761.26 days) were obtained from TCGA. Sub-images that contained a viable tumor area, showing sufficient histologic characteristics, and that did not have any staining artifact were extracted. Several clinical measures and imaging features, including conventional (intensity, morphology) and advanced textures features (gray-level co-occurrence matrix and gray-level run-length matrix), extracted from the sub-images were further used for training the support vector machine model with linear configuration. We sought to evaluate the combined effect of conventional imaging, clinical, and texture features by assessing the predictive value of each feature type and their combinations through a predictive classifier. The texture features were successfully validated on the glioma patients in 10-fold cross-validation (accuracy = 75.12%, AUC = 0.652). The addition of texture features to clinical and conventional imaging features improved grade prediction compared to the models trained on clinical and conventional imaging features alone (p = 0.045 and p = 0.032 for conventional imaging features and texture features, respectively). The integration of imaging, texture, and clinical features yielded a significant improvement in accuracy, supporting the synergistic value of these features in the predictive model. The findings suggest that the texture features, when combined with conventional imaging and clinical markers, may provide an objective, accurate, and integrated prediction of glioma grades. The proposed digital pathology imaging-based marker may help to (i) stratify patients into clinical trials, (ii) select patients for targeted therapies, and (iii) personalize treatment planning on an individual person basis.

Project description:Gliomas are primary brain tumors that originate from glial cells. Classification and grading of these tumors is critical to prognosis and treatment planning. The current criteria for glioma classification in central nervous system (CNS) was introduced by World Health Organization (WHO) in 2016. This criteria for glioma classification requires the integration of histology with genomics. In 2017, the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy (cIMPACT-NOW) was established to provide up-to-date recommendations for CNS tumor classification, which in turn the WHO is expected to adopt in its upcoming edition. In this work, we propose a novel glioma analytical method that, for the first time in the literature, integrates a cellularity feature derived from the digital analysis of brain histopathology images integrated with molecular features following the latest WHO criteria. We first propose a novel over-segmentation strategy for region-of-interest (ROI) selection in large histopathology whole slide images (WSIs). A Deep Neural Network (DNN)-based classification method then fuses molecular features with cellularity features to improve tumor classification performance. We evaluate the proposed method with 549 patient cases from The Cancer Genome Atlas (TCGA) dataset for evaluation. The cross validated classification accuracies are 93.81% for lower-grade glioma (LGG) and high-grade glioma (HGG) using a regular DNN, and 73.95% for LGG II and LGG III using a residual neural network (ResNet) DNN, respectively. Our experiments suggest that the type of deep learning has a significant impact on tumor subtype discrimination between LGG II vs. LGG III. These results outperform state-of-the-art methods in classifying LGG II vs. LGG III and offer competitive performance in distinguishing LGG vs. HGG in the literature. In addition, we also investigate molecular subtype classification using pathology images and cellularity information. Finally, for the first time in literature this work shows promise for cellularity quantification to predict brain tumor grading for LGGs with IDH mutations.

Project description:ObjectivesThis study aimed to explore and develop artificial intelligence approaches for efficient classification of pulmonary nodules based on CT scans.Materials and methodsA number of 1007 nodules were obtained from 551 patients of LIDC-IDRI dataset. All nodules were cropped into 64 × 64 PNG images , and preprocessing was carried out to clean the image from surrounding non-nodular structure. In machine learning method, texture Haralick and local binary pattern features were extracted. Four features were selected using principal component analysis (PCA) algorithm before running classifiers. In deep learning, a simple CNN model was constructed and transfer learning was applied using VGG-16 and VGG-19, DenseNet-121 and DenseNet-169 and ResNet as pre-trained models with fine tuning.ResultsIn statistical machine learning method, the optimal AUROC was 0.885 ± 0.024 with random forest classifier and the best accuracy was 0.819 ± 0.016 with support vector machine. In deep learning, the best accuracy reached 90.39% with DenseNet-121 model and the best AUROC was 96.0%, 95.39% and 95.69% with simple CNN, VGG-16 and VGG-19, respectively. The best sensitivity reached 90.32% using DenseNet-169 and the best specificity attained was 93.65% when applying the DenseNet-121 and ResNet-152V2.ConclusionDeep learning methods with transfer learning showed several benefits over statistical learning in terms of nodule prediction performance and saving efforts and time in training large datasets. SVM and DenseNet-121 showed the best performance when compared with their counterparts. There is still more room for improvement, especially when more data can be trained and lesion volume is represented in 3D.Clinical relevance statementMachine learning methods offer unique opportunities and open new venues in clinical diagnosis of lung cancer. The deep learning approach has been more accurate than statistical learning methods. SVM and DenseNet-121 showed superior performance in pulmonary nodule classification.

Dataset Information

Classification of the glioma grading using radiomics analysis.

Publications

Classification of the glioma grading using radiomics analysis.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets